YARW — YARROW BIOSCIENCE Share News
0.000.00%
Last trade - 00:00- $181.86m
- $158.94m
- $0.57m
U.S. STOCKS ON THE MOVE-GameStop, Kroger, Rocket Lab
U.S. STOCKS ON THE MOVE-Oracle, Oklo, Kroger
U.S. STOCKS ON THE MOVE-Novo Nordisk, Oracle, Adobe
Yarrow Bioscience falls on $150 mln stock sale
Brief: Yarrow Bioscience Announces Pricing Of $150 Million Underwritten Public Offering
Brief: Yarrow Bioscience Reports Second Quarter 2026 Financial Results And Provides Business Update
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
NASDAQ RESUMED AT 08:40 AM
Brief: Vyne Therapeutics And Yarrow Bioscience Announce Merger Agreement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
VYNE Therapeutics Q3 net loss narrows, strategic review ongoing
Brief: VYNE Therapeutics Q3 Revenue USD 169 Thousand
Vyne Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Altria, Meta, FuboTV
U.S. STOCKS ON THE MOVE-Electronic Arts, AEP, Peloton Interactive
Vyne halts skin disease drug trial after failure; shares plunge